{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:16:01Z","timestamp":1770351361374,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,4,11]],"date-time":"2010-04-11T00:00:00Z","timestamp":1270944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00404-010-1456-7","type":"journal-article","created":{"date-parts":[[2010,4,10]],"date-time":"2010-04-10T02:03:28Z","timestamp":1270865008000},"page":"369-371","source":"Crossref","is-referenced-by-count":7,"title":["Dydrogesterone and other progestins in benign breast disease: an overview"],"prefix":"10.1007","volume":"283","author":[{"given":"Adolf E.","family":"Schindler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,11]]},"reference":[{"key":"1456_CR1","first-page":"212","volume":"22","author":"AE Schindler","year":"1989","unstructured":"Schindler AE (1989) \u00c4tiologie und Epidemiologie gutartiger Ver\u00e4nderungen der Brust. Gyn\u00e4kologe 22:212\u2013215","journal-title":"Gyn\u00e4kologe"},{"key":"1456_CR2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1067\/mob.2003.201","volume":"188","author":"J Eden","year":"2003","unstructured":"Eden J (2003) Progestins and breast cancer. Am J Obstet Gynecol 188:1123\u20131131","journal-title":"Am J Obstet Gynecol"},{"key":"1456_CR3","volume-title":"Progestins and antiprogestins in clinical practice","author":"R Sitruk-Ware","year":"2000","unstructured":"Sitruk-Ware R, Mishell DR (2000) Progestins and antiprogestins in clinical practice. Marcel Dekker, New York"},{"key":"1456_CR4","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1128\/MCB.11.10.5032","volume":"11","author":"EA Musgrove","year":"1991","unstructured":"Musgrove EA, Lee CSL, Sutherland R (1991) Progestins both stimulate and inhibit breast cancer cell cycle progression, while increasing expression of transforming growth factor, epidermal growth factor receptor, c-fos and c-myc genes. Mol Cell Biol 11:5032\u20135043","journal-title":"Mol Cell Biol"},{"key":"1456_CR5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bjc.1994.291","volume":"70","author":"G Plu-Bureau","year":"1994","unstructured":"Plu-Bureau G, Le M, Sitruk-Ware R, Thalabard J (1994) Progestogen use and the decreased risk of breast cancer in a cohort of premenopausal women with benign breast disease. Br J Cancer 70:270\u2013277","journal-title":"Br J Cancer"},{"key":"1456_CR6","first-page":"280","volume":"3","author":"P Mauvais-Javis","year":"1988","unstructured":"Mauvais-Javis P (1988) Mastodynia and fibrocystic breast disease. Curr Ther Endocrinol Metab 3:280\u2013284","journal-title":"Curr Ther Endocrinol Metab"},{"key":"1456_CR7","first-page":"269","volume":"19","author":"J Barrat","year":"1990","unstructured":"Barrat J, de Lignieres B, Marpeau L et al (1990) Effect in vivo de l\u2032adminstration locale de progesterone sur l\u2032activit\u00e9 mitotique de galactophores humaines. J Gyn Obstet Biol Reprod 19:269\u2013274","journal-title":"J Gyn Obstet Biol Reprod"},{"key":"1456_CR8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0015-0282(16)57482-2","volume":"63","author":"KJ Chang","year":"1995","unstructured":"Chang KJ, Lee TTY, Linares-Gruz G (1995) Influence of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fert Steril 63:785\u2013791","journal-title":"Fert Steril"},{"key":"1456_CR9","unstructured":"Kutten F, Malet C, Leygue E et al (1994) Antiestrogen action of progestogens in human breast cells. In: Berg G, Hammar M (eds) The modern management of menopause. Canforth, Parthenon, pp 419\u2013433"},{"key":"1456_CR10","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1158\/1055-9965.EPI-08-0380","volume":"17","author":"TE Rohan","year":"2008","unstructured":"Rohan TE, Negassa A, Chlebowski RT et al (2008) Estrogen plus progestogen and risk of benign proliferative breast disease. Cancer Epidemiol Biomark Prev 17:2337\u20132343","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1456_CR11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/s-2003-39061","volume":"55","author":"H Seeger","year":"2003","unstructured":"Seeger H, Wallwiener D, Mueck AO (2003) The effect of progesterone and synthetic progestins in serum and estradiol-stimulated proliferation of human breast cancer cells. Hormone Metab Res 55:76","journal-title":"Hormone Metab Res"},{"issue":"Suppl 6","key":"1456_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/gye.15.s6.37.43","volume":"15","author":"UH Winkler","year":"2001","unstructured":"Winkler UH, Schindler AE, Brinkmann US, Ebert C, Oberhoff C (2001) Cyclic progestin therapy for the management of mastopathy and mastodynia. Gynecol Endocrinol 15(Suppl 6):37\u201343","journal-title":"Gynecol Endocrinol"},{"key":"1456_CR13","unstructured":"Goebel R, Junkermann R, von Fournier D (1989) Danazol-Therapie bei gutartigen Brusterkrankungen. Gyn\u00e4kologe 22:262\u2013270"},{"key":"1456_CR14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0028-2243(92)90177-Z","volume":"43","author":"S Uzan","year":"1992","unstructured":"Uzan S, Denis C, Pomi V, Varin C (1992) Double-blind trial of promegestone (R5020) and lynestrenol in the treatment of benign breast disease. Eur J Gynecol Obstet Reprod Biol 43:219\u2013227","journal-title":"Eur J Gynecol Obstet Reprod Biol"},{"key":"1456_CR15","first-page":"5","volume":"6","author":"H Vorher","year":"1988","unstructured":"Vorher H (1988) Gutartige Brustver\u00e4nderungen: Was ist in Praxi zu tun? Gyne International 6:5\u201310","journal-title":"Gyne International"},{"key":"1456_CR16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/09513590902836536","volume":"25","author":"AE Schindler","year":"2009","unstructured":"Schindler AE, Henkel A, Christensen B, Moore C, Oettel M (2009) Dienogest and the breast. Gynecol Endocrinol 25:472\u2013474","journal-title":"Gynecol Endocrinol"},{"key":"1456_CR17","doi-asserted-by":"crossref","unstructured":"V Fournier D, Kubli F, Bauer M, Weber E (1981) Hochdosierte Gestagen-Langzeit-Therapie beim Corpuskarzinom, Einfluss auf \u00dcberlebenszeit. Geburtsh Frauenheilk. 41:266\u2013270","DOI":"10.1055\/s-2008-1036820"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-010-1456-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1456-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:54:02Z","timestamp":1559051642000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-010-1456-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,11]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1456"],"URL":"https:\/\/doi.org\/10.1007\/s00404-010-1456-7","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,11]]}}}